BTK resynthesis was faster in patients with chronic lymphocytic leukemia (CLL) than in healthy volunteers; therefore, it is hypothesized that complete/sustained BTK occupancy may improve the efficacy outcomes [27]. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.